We are live on
!
Find out more
SGH
Sivik Global Healthcare Portfolio holdings
AUM
$132M
1-Year Est. Return
24.1%
This Fund
S&P 500
This Quarter
Est. Return
+18.03%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$271M
AUM Growth
+$85.9M
(+46%)
Cap. Flow
+$61M
Cap. Flow
% of AUM
22.49%
Top 10 Holdings %
Top 10 Hldgs %
30.66%
Holding
68
New
20
Increased
25
Reduced
11
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$6.64M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$5.6M |
| 3 |
Sanofi
SNY
|
+$5.57M |
| 4 |
CELG
Celgene Corp
CELG
|
+$5.25M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$3.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$7.6M |
| 2 |
UnitedHealth
UNH
|
+$6.97M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$5.38M |
| 4 |
Zimmer Biomet
ZBH
|
+$2.07M |
| 5 |
Intuitive Surgical
ISRG
|
+$1.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 92.84% |
| 2 | Energy | 1.43% |
| 3 | Utilities | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sarepta Therapeutics
SRPT
$1.9B
| $1.79M | 0.66% |
15,000
-5,000
| -25% | -$643K |
|
|
EAS
52
DELISTED
ENERGY EAST CORP (HOLD CO)
EAS
| $1.73M | 0.64% |
+20,000
| New | +$1.73M |
|
53
Agios Pharmaceuticals
AGIO
$2.01B
| $1.69M | 0.62% |
25,000
+10,000
| +67% | +$582K |
|
|
SAGE
54
DELISTED
Sage Therapeutics
SAGE
| $1.59M | 0.59% |
10,000
| – | – |
|
55
Puma Biotechnology
PBYI
$467M
| $1.55M | 0.57% |
+40,000
| New | +$1.22M |
|
56
DexCom
DXCM
$33.7B
| $1.49M | 0.55% |
50,000
+20,000
| +67% | +$703K |
|
|
AKRX
57
DELISTED
Akorn Inc
AKRX
| $1.29M | 0.47% |
+365,700
| New | +$1.4M |
|
|
SGEN
58
DELISTED
Seagen Inc. Common Stock
SGEN
| $732K | 0.27% |
+10,000
| New | +$712K |
|
|
59
Cigna
CI
$72.6B
| – | – |
-40,000
| Closed | -$7.6M |
|
60
Cencora
COR
$61.4B
| – | – |
-10,000
| Closed | -$744K |
|
61
Haemonetics
HAE
$3.95B
| – | – |
-5,000
| Closed | -$500K |
|
62
McKesson
MCK
$105B
| – | – |
-15,000
| Closed | -$1.66M |
|
63
Moderna
MRNA
$24.5B
| – | – |
-25,000
| Closed | -$382K |
|
|
64
UnitedHealth
UNH
$363B
| – | – |
-28,000
| Closed | -$6.97M |
|
|
65
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| – | – |
-75,000
| Closed | -$5.38M |
|
|
66
Zimmer Biomet
ZBH
$18.1B
| – | – |
-20,600
| Closed | -$2.07M |
|
|
LOXO
67
DELISTED
Loxo Oncology, Inc
LOXO
| – | – |
-10,000
| Closed | -$1.4M |
|
Similar funds
AFP
TCPW
PCGDR
ACM
9C
STFP
ADEF
AC
Sivik Global Healthcare's Q1 2019 Portfolio in Review
As of Q1 2019, Sivik Global Healthcare held 68 positions worth $271M, up 46% from $186M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Sivik Global Healthcare deployed $61M of net new capital in Q1 2019, opening 20 new positions and adding to 25 existing holdings. Its largest new stake was Novo Nordisk: 270,000 shares worth $7.06M.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 91% a quarter earlier, followed by Energy and Utilities.
On the sell side, the largest reduction was Intuitive Surgical, an estimated $1.87M trimmed.
- Sivik Global Healthcare's largest Q1 2019 buy was Novo Nordisk: 270,000 shares worth $7.06M.
- Sivik Global Healthcare added most to GW Pharmaceuticals Plc American Depositary Shares in Q1 2019, an estimated $3.72M increase.
- Sivik Global Healthcare's biggest Q1 2019 reduction was Intuitive Surgical, cutting an estimated $1.87M.
- Sivik Global Healthcare fully exited Cigna in Q1 2019, selling an estimated $7.6M.
- Sivik Global Healthcare's ten largest holdings make up 31% of its $271M portfolio in Q1 2019.
- Sivik Global Healthcare opened 20 new positions and closed 9 in Q1 2019.
- Sivik Global Healthcare's portfolio value rose 46% quarter-over-quarter to $271M.
Based on Sivik Global Healthcare's 13F filing for Q1 2019, filed 8 May 2019.